GlobalTort

GlobalTort

The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy

Category Archives: Science

Subscribe to Science RSS Feed

Toxic Trio – # 3 – Formaldehyde – Per Allianz and Praedicat

Posted in Litigation Industry, Mass Tort Issues, Science, Uncategorized
As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio associated with some cosmetics. Again, this is an innovative effort, and deserves careful consideration. The third member of the “toxic trio” substances is formaldehyde. The facts and assessment of the future are – again… Continue Reading

Toxic Trio – # 2 – Toluene – Per Allianz and Praedicat

Posted in Litigation Industry, Mass Tort Issues, Science
As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio associated with some cosmetics. This is an innovative effort, and one that deserves careful consideration. One of the “toxic trio” substances is toluene. The report includes the following data, and Praedicat’s assessment of where… Continue Reading

Allianz and Praedicat Point Fingers at “Toxic Trio” in Cosmetics – #1 is dibutyl phthalate (DBP)

Posted in Litigation Industry, Mass Tort Issues, Science
A few far sighted liability insurers are paying attention to molecular science as to alleged or actual toxins, often aided by the ground-breaking work at Praedicat to assess the medical and scientific literature as to various actual or alleged toxins. See this February 7, 2014  post regarding Praedicat’s work and vision. Some also are taking… Continue Reading

New Article Touches on Genomics and Causation as to Mesothelioma

Posted in Asbestos, Cancer, Mass Tort Issues, Science
It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote about the topic as part of a broader paper on alternative causation issues. The article was published in Mealey’s Asbestos; it is: Defense Strategies For Alternative Causation Arguments In Asbestos Case, … Continue Reading

Notable New Study and Paper on 198 Persons with Mesotheliomas and Germline Variants in Cancer Associated Genes

Posted in Asbestos, Cancer, Science
Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper by Panou and colleagues published in mid- August in the Journal of Clinical Oncology. The paper concludes that a significant proportion (12%) of patients with malignant mesotheliomas carry inherited (germline) mutations in cancer-associated… Continue Reading

Free Online Access to Evidence from Glyphosate Trial (Johnson Case)

Posted in Cancer, Litigation Industry, Mass Tort Issues, Science
For those of us who are junkies for trials involving alleged or actual toxins, there’s a good resource online for the ongoing Johnson trial involving glyphosate/RoundUp.  The plaintiff’s firm for the ongoing Round Up trial  (the Johnson case) seems to be posting pretty much everything online at the firm’s web site; trial exhibits, trial transcripts… Continue Reading

Respected Stem Cell Scientists Comment On Possible Social Value of Plaintiff Suits Against Some Stem Cell Clinics

Posted in Litigation Industry, Science
Seldom do I see articles in which scientists comment on litigation, much less comment favorably. But two just popped up. One is a brief, comment type article from a respected, well-published stem cell scientist who has been following to some degree lawsuits filed against some “stem cell clinics.”  More specifically, “Dr. Paul Knoepfler (@pknoepfler) is… Continue Reading

“Nightingale Health & UK Biobank announce major initiative to analyze 500,000 blood samples” in 30 months for 200 biomarkers

Posted in Cancer, Science
We continue to see increases in the the scale and pace of the development of molecular and genetic knowledge. A recent example arises from the announcement of serious plans for detailed analysis of 500,000 blood samples for 200 biomarkers. That’s impressive by itself. Then, note the related factors. The new data will be related back… Continue Reading

“Blockchain and the Law CLE Now Available On Demand”

Posted in Offtopic, Science
For those interested in blockchain and CLE, an excellent, on demand program from The Center for Law, Science & Innovation at the ASU Sandra Day O’Connor School of Law. _____________________________________ “The Center for Law, Science & Innovation recently hosted a Blockchain Speaker Series that brought together CEOs, legislators, and legal professionals to discuss present and future legal challenges… Continue Reading

Concussion Trial Underway In Texas – What Did the NCAA Know and When Did It Know It, Featured in Opening Arguments

Posted in Concussion, Litigation Industry, Science
Trial is now underway in a football player’s concussion case against a college (Texas). A June 11, 2018 article at Quartz recaps some of the facts about the plaintiff, and possible implications for the sport at the college level. LAW360 is covering the trial, as is Courtroom View Network. A June 13, 2018 article from… Continue Reading

Molecular Biomarker Revolution and Torts – “Blood Tests Developed That Identify Women at Risk of Preterm Birth”

Posted in Litigation Industry, Science
The molecular biomarker revolution continues and will reshape many topics at the intersections between science and law. A recent example lies in an article explaining that  researchers are moving fruitfully down apath to developing a cheap, non-invasive test to predict risk of pre-term birth. How did they do that? To simplify, tesearchers took a continuing… Continue Reading

Mesothelioma Therapy – Preliminary Report – 1 Complete Response

Posted in Asbestos, Cancer, Science
Therapy with CAR-T cells (artificially modified t-cells) is a “hot” idea these days in cancer therapy.  Last week, the Mesothelioma Applied Research Foundation highlighted some early days, limited success in researchers at MMSK using CAR T cells in a clinical trial setting involving treatment of persons suffering from mesotheliomas; see this May 18, 2018 article. … Continue Reading

Nathan Schactman Asks: “P-Values: Pernicious or Perspicacious?”

Posted in Evidence, Litigation Industry, Science
Statistical analysis tools remain topics that are comfortable for relatively few lawyers. One of them is Nathan Schactman. In a new blog post, he critiques a newish law review article on the topic.Kingsley R. Browne, “Pernicious P-Values: Statistical Proof of Not Very Much,” 42 Univ. Dayton L. Rev. 113 (2017) .The critique is well-worth reading, in… Continue Reading

Serendipity, Science and A Good Person

Posted in Offtopic, Science
A remarkable feel good story … on Mother’s Day (May 12, 2018) from the Optimist at the WP. It’s also a story of serendipity in science, and how it transformed a medical condition beginning in 1967.  Here’s the headline/teaser: “For six decades, ‘the man with the golden arm’ donated blood — and saved 2.4 million… Continue Reading

Science Week Underway Before a Federal Judge and a State Judge Regarding Monsanto’s Glysophate

Posted in Pesticides, Science
Innovative hearings continue regarding presentations of scientific data regarding alleged toxins.  The newest example is this week “science week” regarding lawsuits related to Monsanto’s glysophate. A summary of day 1 is available through a March 6, 2018 article at LAW360 (paywall). In short, plaintiff’s experts were on the stand. For a plaintiff friendly preview, see… Continue Reading

Readers of Science Magazine Outline the Future: The next generation’s Frankenstein films

Posted in Humor, Science
I’m an optimist about science and the future. But some people are not so optimist, or at least focus on negative possibilities. An open access article from Science provides a pretty good set of hypothetical future books/films that might be as groundbreaking as was Frankenstein. Gene editing plainly has plenty of people thinking about ill-intended… Continue Reading